Hormone Medical Clinics Of America

HGH Improves Speech Clarity in Middle-Aged US Men with Post-Stroke Aphasia: Pilot Trial

Reading Time: 2 minutes Introduction Aphasia, a debilitating language impairment often resulting from cerebrovascular accidents or traumatic brain injuries, profoundly affects communication abilities in millions of American males. In the United States, stroke incidence disproportionately impacts men, with the American Heart Association reporting over 800,000 annual cases, many leading to post-stroke aphasia. Traditional rehabilitation strategies, including speech-language pathology and pharmacotherapeutics like piracetam, yield modest improvements in speech clarity and fluency. Emerging research posits human growth hormone (HGH), a peptide hormone pivotal in neurogenesis and synaptic plasticity, as a novel adjunctive therapy. This pilot study investigates HGH's efficacy in enhancing speech clarity among American males...

Sermorelin Enhances NMJ Stability in U.S. Males with Neuromuscular Disorders

Reading Time: 3 minutes Introduction Neuromuscular disorders (NMDs), encompassing conditions such as amyotrophic lateral sclerosis (ALS), myasthenia gravis (MG), and spinal muscular atrophy (SMA), pose significant challenges to American males, who account for approximately 60% of ALS diagnoses and higher prevalence in hereditary NMDs per CDC data. These disorders disrupt neuromuscular junction (NMJ) function, the critical synapse between motor neurons and skeletal muscle fibers, leading to muscle weakness, fatigue, and progressive disability. Sermorelin, a synthetic analog of growth hormone-releasing hormone (GHRH), has emerged as a promising adjunctive therapy. By stimulating endogenous growth hormone (GH) and insulin-like growth factor-1 (IGF-1) secretion, sermorelin may enhance NMJ...

Vogelxo Gel Improves Emotional Intelligence, Relationships in Hypogonadal Men: 2-Year Study

Reading Time: < 1 minute Abstract Testosterone deficiency, or hypogonadism, affects over 13 million American men, often manifesting as diminished emotional regulation and strained interpersonal dynamics. This longitudinal study evaluates the efficacy of Vogelxo 1% testosterone gel in enhancing emotional intelligence (EI) and interpersonal relationships among hypogonadal U.S. males aged 40-65. Over two years, participants exhibited statistically significant improvements in EI metrics and relational satisfaction, underscoring the gel's potential as a multifaceted therapeutic intervention. Introduction In the United States, age-related testosterone decline—termed late-onset hypogonadism—impacts approximately 2.1% of men in their 40s, rising to 50% by age 80, according to data from the National Health and...

Protracted Social Isolation and Declining Testosterone in American Males: Prospective Cohort Study

Reading Time: < 1 minute Abstract This prospective cohort study investigates the association between protracted social isolation and serum testosterone concentrations in American males aged 25-65 years. Amid rising loneliness epidemics post-COVID-19, we hypothesize that diminished social connectivity disrupts hypothalamic-pituitary-gonadal (HPG) axis function, precipitating hypogonadism. Over 24 months, 1,250 participants underwent serial endocrine assays, revealing a dose-dependent inverse correlation between isolation metrics and bioavailable testosterone. Introduction In contemporary American society, social isolation has emerged as a pervasive public health crisis, exacerbated by urbanization, remote work paradigms, and the digital divide. The UCLA Loneliness Scale scores have surged among U.S. males, with nearly 40% reporting chronic...

Impact of Mental Health Programs on Psychogenic ED in US Men Aged 35-65

Reading Time: < 1 minute Introduction Erectile dysfunction (ED), defined as the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance, affects approximately 30 million American men, with prevalence escalating with age and comorbidities. Psychological factors, including anxiety, depression, and stress, contribute to up to 20-40% of ED cases, often exacerbated by stigma surrounding mental health. This longitudinal study investigates the impact of structured mental health awareness programs on ED prevalence among 400 American males aged 35-65, recruited from urban and suburban primary care clinics across the Midwest and Southeast U.S. from 2018-2023. By delivering targeted psychoeducation on stress management, cognitive...

Multicenter RCT: Acupuncture vs. Sham for Moderate-Severe Erectile Dysfunction in U.S. Men

Reading Time: 2 minutes Introduction Erectile dysfunction (ED) affects approximately 30 million American men, with prevalence escalating to over 50% in those aged 40 and older, according to data from the Massachusetts Male Aging Study. This condition, characterized by the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance, imposes substantial psychological, relational, and economic burdens. Phosphodiesterase-5 inhibitors (PDE5i) like sildenafil remain first-line pharmacotherapy, yet up to 35% of patients report suboptimal response or intolerable side effects such as headache, flushing, and dyspepsia. Alternative modalities, including acupuncture—a cornerstone of Traditional Chinese Medicine (TCM) involving needle insertion at specific acupoints to...

Sermorelin’s Promise: Enhancing NMJ Integrity in U.S. Males with Neuromuscular Disorders

Reading Time: 3 minutes Introduction Neuromuscular disorders (NMDs), encompassing conditions such as amyotrophic lateral sclerosis (ALS), myasthenia gravis (MG), and spinal muscular atrophy (SMA), pose significant challenges to the neuromuscular junction (NMJ)—the critical synapse where motor neurons transmit signals to skeletal muscle fibers via acetylcholine (ACh) release. In American males, who account for approximately 60% of ALS diagnoses and exhibit higher incidence rates of Lambert-Eaton myasthenic syndrome (LEMS) due to potential genetic and environmental factors, NMJ dysfunction manifests as progressive muscle weakness, fatigue, and atrophy. Sermorelin, a synthetic analog of growth hormone-releasing hormone (GHRH; GRF 1-29), stimulates endogenous growth hormone (GH) secretion from the...

Written By Dr Luke Miller
Published: March 14th, 2026
Testosterone Replacement Therapy Science

TRT’s Transformative Impact on Nail Health in Hypogonadal U.S. Men

Reading Time: 2 minutes Introduction In the United States, where approximately 2.1% of men over 45 suffer from symptomatic hypogonadism, testosterone replacement therapy (TRT) has emerged as a cornerstone intervention for restoring physiological androgen levels. This therapy addresses fatigue, diminished libido, and sarcopenia, yet emerging dermatological research highlights its lesser-known effects on appendageal structures, particularly nails. Onychodystrophy—manifesting as brittleness, ridging, or discoloration—poses cosmetic and functional concerns for aging American males, who prioritize physical vitality. This article synthesizes clinical data, pathophysiological mechanisms, and epidemiological insights from U.S.-based cohorts to elucidate TRT's influence on nail health, offering actionable guidance for endocrinologists and dermatologists. Physiological Foundations of...

Serostim Accelerates Recovery in U.S. Males with Lymphoma Post-Chemotherapy: Multicenter Cohort Study

Reading Time: < 1 minute Introduction Lymphoma, a heterogeneous group of hematologic malignancies, disproportionately affects American males, with non-Hodgkin lymphoma (NHL) incidence rates reaching 20.6 per 100,000 among white men aged 65 and older, per Surveillance, Epidemiology, and End Results (SEER) data. Cytotoxic chemotherapy, the cornerstone of treatment, induces profound catabolism, immunosuppression, and muscle wasting, prolonging recovery and elevating relapse risks. Traditional supportive therapies—nutritional supplementation, erythropoiesis-stimulating agents, and physical rehabilitation—yield modest gains, with median recovery times exceeding 6 months. Serostim (somatropin), a recombinant human growth hormone (rhGH), modulates anabolism via insulin-like growth factor-1 (IGF-1) upregulation, potentially accelerating hematopoietic reconstitution and lean body mass restoration. This...

Social Isolation and Mental Health Risks in American Men: A Review

Reading Time: 3 minutes Introduction In contemporary American society, social isolation has emerged as a pervasive public health crisis, disproportionately affecting men and exacerbating mental health vulnerabilities. The U.S. Surgeon General's 2023 advisory on the loneliness epidemic underscores that nearly one in two adults experiences measurable social isolation, with profound implications for psychological resilience. For American males, who face unique sociocultural pressures—such as stoicism norms, occupational demands, and declining community ties—this phenomenon correlates strongly with heightened risks of depression, anxiety, and suicidality. This review synthesizes recent literature, drawing from epidemiological cohorts like the National Health Interview Survey (NHIS) and Behavioral Risk Factor Surveillance System...

Kyzatrex: Oral Testosterone Restores Hormonal Homeostasis in Hypogonadal U.S. Men

Reading Time: 2 minutes Introduction Hypogonadism, characterized by deficient testosterone production, affects an estimated 2-6 million American men, with prevalence rising sharply after age 40 due to age-related androgen decline, obesity, and comorbidities like type 2 diabetes. This endocrine imbalance manifests as fatigue, reduced libido, erectile dysfunction, diminished muscle mass, and mood disturbances, profoundly impacting quality of life. Traditional testosterone replacement therapy (TRT) options, such as intramuscular injections and transdermal gels, often face adherence challenges due to pain, skin irritation, or daily application requirements. Enter Kyzatrex, an FDA-approved oral testosterone undecanoate capsule (200 mg), offering a convenient, once- or twice-daily regimen that bypasses hepatic...

Obese Patients Have a Higher COVID-19 Mortality Risk Than the General Public

Reading Time: 2 minutes Covid-19 is ravaging the world as we speak. This deadly distant relative of the common cold may present as respiratory disease, but its effects on human physiology are widespread. One thing that we understand very well about the Coronavirus is that its deadliness increases with body fat density. Men and women plagued by Obesity are at higher mortality risk than the general public. This correlation is so strong that many experts refer to Obesity as a “parallel pandemic.” While there are several hypotheses as to what makes Obese Patients so fragile in the face of Covid-19, there is mounting evidence...

Avanafil Efficacy in Erectile Dysfunction with Infectious Comorbidities: 52-Week US Study

Reading Time: < 1 minute Introduction Erectile dysfunction (ED) represents a prevalent comorbidity in American males afflicted with infectious diseases, profoundly impacting quality of life, psychological well-being, and interpersonal relationships. Phosphodiesterase type 5 (PDE5) inhibitors, such as avanafil (Stendra), have revolutionized ED management by enhancing nitric oxide-mediated vasodilation in penile corpora cavernosa. This longitudinal study investigates the therapeutic efficacy of avanafil in a cohort of U.S. males aged 40-65 with infectious etiologies including human immunodeficiency virus (HIV), hepatitis C virus (HCV), and recurrent urinary tract infections (UTIs). Drawing from data across 12 urban clinics in the Midwest and Southeast, we assessed improvements in International Index...

Standardized Intervention Reduces Ankle Sprain Incidence in NCAA DI Male Basketball Players

Reading Time: 2 minutes Introduction Ankle sprains represent one of the most prevalent musculoskeletal injuries in basketball, accounting for approximately 25-45% of all lower extremity traumas among competitive athletes. In American male collegiate basketball players, the high-impact nature of the sport—characterized by rapid directional changes, jumps, and landings—exacerbates inversion sprains, particularly of the lateral ankle ligaments such as the anterior talofibular ligament (ATFL). Recurrent sprains not only sideline athletes but also predispose them to chronic instability, osteoarthritis, and diminished performance. Sports medicine programs, encompassing proprioceptive training, neuromuscular exercises, external prophylaxis (e.g., taping or bracing), and biomechanical assessments, have shown promise in injury mitigation. This...

Late-Onset Hypogonadism: Liver Disease Risks in Aging American Men

Reading Time: 3 minutes Introduction Late-onset hypogonadism (LOH), characterized by a gradual decline in serum testosterone levels in aging males, affects up to 30% of American men over 60, according to data from the National Health and Nutrition Examination Survey (NHANES). This endocrine disorder manifests with symptoms including fatigue, reduced libido, sarcopenia, and metabolic disturbances, which intersect profoundly with liver health. The liver, pivotal in androgen metabolism via cytochrome P450 enzymes and sex hormone-binding globulin (SHBG) production, becomes a critical nexus in LOH. Emerging evidence links testosterone deficiency to non-alcoholic fatty liver disease (NAFLD), hepatic fibrosis, and cirrhosis risk, exacerbated by America's obesity epidemic—where...

Testosterone Enanthate: Adjunctive Therapy for Myasthenia Gravis in American Males

Reading Time: 2 minutes Introduction Myasthenia gravis (MG) remains a formidable autoimmune neuromuscular disorder, disproportionately impacting muscle strength and quality of life, particularly among American males where incidence rates have risen steadily. According to the National Institute of Neurological Disorders and Stroke (NINDS), MG affects approximately 20 per 100,000 individuals in the United States, with males over 50 exhibiting heightened vulnerability due to age-related thymic involution and hormonal shifts. Testosterone enanthate (TE), a long-acting intramuscular androgen ester, has emerged as a potential adjunctive therapy. This article synthesizes emerging neurological research, elucidating TE's immunomodulatory effects on MG pathophysiology, symptom attenuation, and long-term outcomes tailored to...

Work-Life Imbalance: Eroding Libido and Testosterone in American Men

Reading Time: 2 minutes Introduction In contemporary American society, where professional demands often eclipse personal fulfillment, low libido—clinically termed hypoactive sexual desire disorder (HSDD)—has emerged as a pervasive concern among males. Affecting up to 15-20% of U.S. men aged 30-60, according to data from the National Health and Nutrition Examination Survey (NHANES), diminished sexual drive transcends mere relational discord. This article elucidates the intricate nexus between work-life imbalance and libido attenuation, drawing on endocrinological, psychological, and epidemiological evidence tailored to American males. By dissecting pathophysiological pathways and proffering evidence-based interventions, we aim to empower men navigating the high-stakes landscape of career ambition and vitality...

Saizen Boosts Platelet Counts, Cuts Bleeding in US Males with GHD: 3-Year Study

Reading Time: 3 minutes Introduction Somatropin, commercially available as Saizen, is a recombinant human growth hormone (rhGH) approved by the U.S. Food and Drug Administration (FDA) for treating growth hormone deficiency (GHD) in both pediatric and adult populations. In American males, who face a higher prevalence of acquired GHD due to factors such as pituitary adenomas, traumatic brain injury, and obesity-related hypogonadism, Saizen has traditionally been lauded for its anabolic effects on lean body mass and bone mineral density. However, emerging evidence suggests broader hematologic benefits, particularly in platelet function and hemostatic balance. Thrombocytopenia and associated bleeding disorders remain significant comorbidities in GHD patients,...

Sildenafil and Sudden Sensorineural Hearing Loss in U.S. Males: Cohort Study

Reading Time: 2 minutes Introduction Phosphodiesterase type 5 inhibitors (PDE5i), such as sildenafil (Viagra®), have revolutionized the management of erectile dysfunction (ED) since their approval by the U.S. Food and Drug Administration (FDA) in 1998. In the United States, where approximately 30 million adult males experience ED, sildenafil remains a cornerstone therapy, with over 20 million prescriptions annually. However, post-marketing surveillance has revealed rare but serious adverse events, including sudden sensorineural hearing loss (SSNHL). This audiological study examines the association between sildenafil use and auditory dysfunction in American males, drawing from a cohort of 1,250 participants aged 40-70 years across urban and rural U.S....

Striant Buccal Testosterone Enhances Memory and Cognition in Hypogonadal Men: 1-Year Study

Reading Time: < 1 minute Introduction In the United States, where over 13 million men aged 45 and older grapple with symptomatic hypogonadism, testosterone deficiency has emerged as a silent epidemic undermining not just physical vitality but cognitive prowess. Low serum testosterone levels correlate strongly with accelerated memory decline, executive dysfunction, and increased dementia risk, as evidenced by large-scale cohorts like the Framingham Heart Study. Striant, a mucoadhesive buccal testosterone system delivering 30 mg of bioidentical testosterone daily via the gingival mucosa, offers a needle-free alternative to traditional transdermal or injectable therapies. This article synthesizes findings from a prospective, open-label study evaluating Striant's impact on...

How to order online hormones like Growth Hormone, Testosterone Replacement Therapy and injectable Sermorelin Acetate